Table V.
Metascape enrichment analysis for the co-expressed genes of cancer susceptibility candidate 9.
| GO ID | Category | Term | Count of enriched genes | Log10(P) |
|---|---|---|---|---|
| GO:0045216 | GO Biological Processes | 'Cell-cell junction organization' | 9 | −7.340 |
| GO:0002934 | GO Biological Processes | 'Desmosome organization' | 4 | −7.010 |
| GO:0008544 | GO Biological Processes | 'Epidermis development' | 13 | −6.630 |
| GO:0098609 | GO Biological Processes | 'Cell-cell adhesion' | 15 | −5.420 |
| hsa04390 | KEGG Pathway | 'Hippo signaling pathway' | 6 | −4.030 |
| GO:0060713 | GO Biological Processes | 'Labyrinthine layer morphogenesis' | 3 | −3.960 |
| GO:0043516 | GO Biological Processes | 'Regulation of DNA damage response, signal transduction by p53 class mediator' | 3 | −3.420 |
| GO:0030168 | GO Biological Processes | 'Platelet activation' | 5 | −3.100 |
| GO:0043616 | GO Biological Processes | 'Keratinocyte proliferation' | 3 | −3.020 |
| hsa05130 | KEGG Pathway | 'Pathogenic Escherichia coli infection' | 3 | −2.650 |
| GO:0097193 | GO Biological Processes | 'Intrinsic apoptotic signaling pathway' | 6 | −2.610 |
| M255 | Canonical Pathways | 'PID HIF1 TF pathway' | 3 | −2.420 |
| R-HSA-422356 | Reactome Gene Sets | Regulation of insulin secretion | 3 | −2.190 |
| GO:0070848 | GO Biological Processes | Response to growth factor | 9 | −2.130 |
| R-HSA-6798695 | Reactome Gene Sets | Neutrophil degranulation | 7 | −2.110 |
| R-HSA-5687128 | Reactome Gene Sets | MAPK6/MAPK4 signaling | 3 | −2.060 |
GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; MAPK, mitogen-activated protein kinase.